The Rate of Secondary Malignancies After Radical Prostatectomy Versus External Beam Radiation Therapy for Localized Prostate Cancer: A Population-Based Study on 17,845 Patients

International Journal of Radiation Oncology Biology Physics

Volumn 76, Issue 2, 2010, Pages 342-348

  Bhojani, Naeem ^a,b   Capitanio, Umberto ^a   Suardi, Nazareno ^c   Jeldres, Claudio ^a,b   Isbarn, Hendrik ^a,d   Shariat, Shahrokh F ^e   Graefen, Markus ^d   Arjane, Philippe ^b   Duclos, Alain ^b   Lattouf, Jean Baptiste ^b   Saad, Fred ^b   Valiquette, Luc ^b   Montorsi, Francesco ^c   Perrotte, Paul ^b   Karakiewicz, Pierre I ^a,b  

^a CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

^c VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

^d UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^e UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Prostate cancer; Radical prostatectomy; radiotherapy; Secondary malignancies

Indexed keywords

ABSOLUTE DIFFERENCE; BLADDER CANCERS; COMORBIDITY; COVARIATES; COX REGRESSION ANALYSIS; EXTERNAL-BEAM RADIATION THERAPY; HAZARD RATIO; INCIDENT RATES; KAPLAN-MEIER; LOCALIZED PROSTATE CANCER; LUNG CANCER; MULTIVARIABLE ANALYSIS; PROSTATE CANCERS; RADICAL PROSTATECTOMY; RECTAL CANCER;

DISEASES; PATIENT MONITORING; PESTICIDE EFFECTS; REGRESSION ANALYSIS;

RADIOTHERAPY;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BLADDER METASTASIS; CANADA; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER LOCALIZATION; COHORT ANALYSIS; COMORBIDITY; CONTROLLED STUDY; EXTERNAL BEAM RADIOTHERAPY; HUMAN; INTERMETHOD COMPARISON; LUNG METASTASIS; MAJOR CLINICAL STUDY; MALE; METASTASIS; OUTCOME ASSESSMENT; POPULATION RESEARCH; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; RECTUM CANCER; SCORING SYSTEM;

ADULT; AGED; AGED, 80 AND OVER; FRANCE; HUMANS; INCIDENCE; KAPLAN-MEIERS ESTIMATE; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASMS, RADIATION-INDUCED; NEOPLASMS, SECOND PRIMARY; PROSTATECTOMY; PROSTATIC NEOPLASMS; QUEBEC; RADIOTHERAPY; RECTAL NEOPLASMS; REGRESSION ANALYSIS; URINARY BLADDER NEOPLASMS;

EID: 73649090396     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2009.02.011     Document Type: Article

References (33)

1. Heidenreich A., Aus G., Bolla M., et al. EAU guidelines on prostate cancer. Eur Urol 53 (2008) 68-80
2. Barre C. Open radical retropubic prostatectomy. Eur Urol 52 (2007) 71-80
3. Berge V., Thompson T., and Blackman D. Additional surgical intervention after radical prostatectomy, radiation therapy, androgen-deprivation therapy, or watchful waiting. Eur Urol 52 (2007) 1036-1043
4. Maffezzini M., Bossi A., and Collette L. Implications of prostate-specific antigen doubling time as indicator of failure after surgery or radiation therapy for prostate cancer. Eur Urol 51 (2007) 605-613 discussion 613
5. Capitanio U., Scattoni V., Freschi M., et al. Radical prostatectomy for incidental (Stage t1a-t1b) prostate cancer: analysis of predictors for residual disease and biochemical recurrence. Eur Urol 54 (2008) 118-125
6. Litwin M.S., McGuigan K.A., Shpall A.I., et al. Recovery of health related quality of life in the year after radical prostatectomy: Early experience. J Urol 161 (1999) 515-519
7. Litwin M.S., Hays R.D., Fink A., et al. Quality-of-life outcomes in men treated for localized prostate cancer. JAMA 273 (1995) 129-135
8. Karakiewicz P.I., Bhojani N., Neugut A., et al. The effect of comorbidity and socioeconomic status on sexual and urinary function and on general health-related quality of life in men treated with radical prostatectomy for localized prostate cancer. J Sex Med 5 (2008) 919-927
9. Hanlon A.L., Watkins Bruner D., Peter R., et al. Quality of life study in prostate cancer patients treated with three-dimensional conformal radiation therapy: Comparing late bowel and bladder quality of life symptoms to that of the normal population. Int J Radiat Oncol Biol Phys 49 (2001) 51-59
10. Lilleby W., Fossa S.D., Waehre H.R., et al. Long-term morbidity and quality of life in patients with localized prostate cancer undergoing definitive radiotherapy or radical prostatectomy. Int J Radiat Oncol Biol Phys 43 (1999) 735-743
11. Leborgne F., and Fowler J. Acute toxicity after hypofractionated conformal radiotherapy for localized prostate cancer: Nonrandomized contemporary comparison with standard fractionation. Int J Radiat Oncol Biol Phys 72 (2008) 770-776
12. Fonteyne V., Villeirs G., Speleers B., et al. Intensity-modulated radiotherapy as primary therapy for prostate cancer: Report on acute toxicity after dose escalation with simultaneous integrated boost to intraprostatic lesion. Int J Radiat Oncol Biol Phys 72 (2008) 799-807
13. Faria S.L., Souhami L., Joshua B., et al. Reporting late rectal toxicity in prostate cancer patients treated with curative radiation treatment. Int J Radiat Oncol Biol Phys 72 (2008) 777-781
14. Ferrer M., Suarez J.F., Guedea F., et al. Health-related quality of life 2 years after treatment with radical prostatectomy, prostate brachytherapy, or external beam radiotherapy in patients with clinically localized prostate cancer. Int J Radiat Oncol Biol Phys 72 (2008) 421-432
15. Mols F., Korfage I.J., Vingerhoets A.J., et al. Bowel, urinary, and sexual problems among long-term prostate cancer survivors: A population-based study. Int J Radiat Oncol Biol Phys 73 (2009) 30-38
16. Kry S.F., Followill D., White R.A., et al. Uncertainty of calculated risk estimates for secondary malignancies after radiotherapy. Int J Radiat Oncol Biol Phys 68 (2007) 1265-1271
17. Damber J.E., and Aus G. Prostate cancer. Lancet 371 (2008) 1710-1721
18. Bostrom P.J., and Soloway M.S. Secondary cancer after radiotherapy for prostate cancer: Should we be more aware of the risk?. Eur Urol 52 (2007) 973-982
19. Moon K., Stukenborg G.J., Keim J., et al. Cancer incidence after localized therapy for prostate cancer. Cancer 107 (2006) 991-998
20. Brenner D.J., Curtis R.E., Hall E.J., et al. Second malignancies in prostate carcinoma patients after radiotherapy compared with surgery. Cancer 88 (2000) 398-406
21. Liauw S.L., Sylvester J.E., Morris C.G., et al. Second malignancies after prostate brachytherapy: Incidence of bladder and colorectal cancers in patients with 15 years of potential follow-up. Int J Radiat Oncol Biol Phys 66 (2006) 669-673
22. Boorjian S., Cowan J.E., Konety B.R., et al. Bladder cancer incidence and risk factors in men with prostate cancer: Results from Cancer of the Prostate Strategic Urologic Research Endeavor. J Urol 177 (2007) 883-887 discussion 887-888
23. Neugut A.I., Ahsan H., Robinson E., et al. Bladder carcinoma and other second malignancies after radiotherapy for prostate carcinoma. Cancer 79 (1997) 1600-1604
24. Kry S.F., Salehpour M., Followill D.S., et al. The calculated risk of fatal secondary malignancies from intensity-modulated radiation therapy. Int J Radiat Oncol Biol Phys 62 (2005) 1195-1203
25. Jeldres C., Suardi N., Capitanio U., et al. High surgical volume is associated with a lower rate of secondary therapy after radical prostatectomy for localized prostate cancer. BJU Int 102 (2008) 463-467
26. Jeldres C., Suardi N., Saad F., et al. High provider volume is associated with lower rate of secondary therapies after definitive radiotherapy for localized prostate cancer. Eur Urol 54 (2008) 97-105
27. Jeldres C., Suardi N., Walz J., et al. Poor overall survival in septa- and octogenarian patients after radical prostatectomy and radiotherapy for prostate cancer: A population-based study of 6183 men. Eur Urol 54 (2008) 107-116
28. Walz J., Gallina A., Perrotte P., et al. Clinicians are poor raters of life-expectancy before radical prostatectomy or definitive radiotherapy for localized prostate cancer. BJU Int 100 (2007) 1254-1258
29. D'Hoore W., Bouckaert A., and Tilquin C. Practical considerations on the use of the Charlson comorbidity index with administrative data bases. J Clin Epidemiol 49 (1996) 1429-1433
30. Baxter N.N., Tepper J.E., Durham S.B., et al. Increased risk of rectal cancer after prostate radiation: a population-based study. Gastroenterology 128 (2005) 819-824
31. Pickles T., and Phillips N. The risk of second malignancy in men with prostate cancer treated with or without radiation in British Columbia, 1984-2000. Radiother Oncol 65 (2002) 145-151
32. Karakiewicz P.I., Bazinet M., Aprikian A.G., et al. Thirty-day mortality rates and cumulative survival after radical retropubic prostatectomy. Urology 52 (1998) 1041-1046
33. Walz J., Montorsi F., Jeldres C., et al. The effect of surgical volume, age and comorbidities on 30-day mortality after radical prostatectomy: A population-based analysis of 9208 consecutive cases. BJU Int 101 (2008) 826-832